Evidence map›Paper›PMID 39372038›Full record

ArticleNAR cancer2024

RNA kinetics influence the response to transcriptional perturbation in leukaemia cell lines.

Izabela Todorovski, Mary-Jane Tsang, Breon Feran, Zheng Fan, Sreeja Gadipally, David Yoannidis, Isabella Y Kong, Stefan Bjelosevic, Sarahi Rivera, Olivia Voulgaris and 7 more

Abstract read
In one paragraph

Article in NAR cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Izabela TodorovskiPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.ORCID https://orcid.org/0000-0002-9488-7508
Mary-Jane TsangPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Breon FeranThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Zheng FanPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Sreeja GadipallyPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
David YoannidisPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Isabella Y KongThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Stefan BjelosevicPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Sarahi RiveraThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.ORCID https://orcid.org/0000-0002-7615-7632
Olivia VoulgarisThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Magnus ZethovenPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.ORCID https://orcid.org/0000-0002-6528-891X
Edwin D HawkinsThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Kaylene J SimpsonPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Gisela Mir ArnauPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Anthony T PapenfussPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Ricky W JohnstonePeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.
Stephin J VervoortPeter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic targeting of dysregulated transcription has emerged as a promising strategy for the treatment of cancers, such as leukaemias. The therapeutic response to small molecule inhibitors of Bromodomain-Containing Proteins (BRD), such as BRD2 and BRD4, P300/cAMP-response element binding protein (CBP) and Cyclin Dependent Kinases (CDKs), is generally attributed to the selective disruption of oncogenic gene expression driven by enhancers, super-enhancers (SEs) and lineage-specific transcription factors (TFs), including the

Identifiers

PMID39372038
PMCPMC11447529

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.